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Background
PPARG plays a key role in adipocyte biology, and Rosigli-
tazone (Rosi), a thiazolidinedione (TZD)/ PPARG agonist,
is a potent insulin-sensitizing agent [1-3]. Recent evidences
demonstrate that adipose tissue inflammation links obesity
with insulin resistance and that the insulin-sensitizing
effects of TZDs result, in part, from their anti-inflamma-
tory properties [4,5]. However the underlying mechanisms
are unclear. Free Fatty Acids (FFAs) are important adipo-
cyte-derived signaling molecules whose plasma levels
are elevated in obese and insulin resistant individuals and
animal models [6,7]. In this study, we establish a link
between free fatty acids (FFAs) and PPARG in the context
of obesity-associated inflammation.
Methodology and methods
We used 3T3L1 mouse cells as a model of mature adipo-
cytes. Conditioned media were prepared from 3T3L1
mature adipocytes exposed to different conditions and
subsequently used for in vitro chemotaxis assays with
Raw264.7 mouse macrophages cells. 10 weeks old males
C57Bl6 mice (littermates) were fed a high fat diet (60%
Kcal fat, Research Diet) where rosiglitazone was directly
mixed by manufacturer. Normal chow diet consisted of
13.5% kcal fat (Lab Diet).
Results
We show that treatment of adipocytes with FFAs down-
regulates PPARG protein and mRNA levels. Knockdown
of adipocyte PPARG resulted in upregulation of MCP1
gene expression and secretion, leading to enhanced
macrophage chemotaxis. Rosi inhibited these effects. In a
high fat feeding mouse model, we show that Rosi treat-
ment decreases recruitment of proinflammatory macro-
phages to epididymal fat. This correlates with decreased
chemokine and decreased chemokine receptor expression
in adipocytes and macrophages, respectively.
Conclusions
In summary, we describe a novel link between FAs,
PPARG, adipocytes, and adipocyte-driven recruitment
of macrophages and thus provide an additional poten-
tial mechanism for the anti-inflammatory and insulin-
sensitizing actions of TZDs.
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